losartan has been researched along with Fibromatosis, Aggressive in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Fibromatosis, Aggressive: A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, DE | 1 |
| Al-Sayed, AA | 1 |
| Trites, J | 1 |
| Wheelock, M | 1 |
| Acott, PD | 1 |
| Midgen, C | 1 |
| Johnson, LB | 1 |
| Bezuhly, M | 1 |
1 other study available for losartan and Fibromatosis, Aggressive
| Article | Year |
|---|---|
Oral Losartan After Limited Mandibulectomy for Treatment of Desmoid-Type Fibromatosis.
Topics: Biopsy; Child, Preschool; Fibromatosis, Aggressive; Humans; Losartan; Male; Mandibular Osteotomy; Ma | 2023 |